Sarcoma

• EMA approval · 2026-07-20
  EMA Authorised: Yondelis (trabectedin) — Pharma Mar S.A.

  Authorised status for Yondelis (trabectedin) in the EU for ovarian neoplasms and sarcoma.

• EMA approval · 2026-03-25
  EMA Authorised: Trabectedin Accord (trabectedin) — Accord Healthcare S.L.U.

  The European Medicines Agency authorised Accord Healthcare's trabectedin (Trabectedin Accord) for use in sarcoma and ovarian cancer.

• EMA approval · 2022-01-11
  EMA Authorised: Beromun (tasonermin) — Belpharma s.a.

  Beromun (tasonermin) has been authorised in the EU for use in sarcoma by Belpharma s.a.